ES2045126T3 - Agentes terapeuticos. - Google Patents

Agentes terapeuticos.

Info

Publication number
ES2045126T3
ES2045126T3 ES88306377T ES88306377T ES2045126T3 ES 2045126 T3 ES2045126 T3 ES 2045126T3 ES 88306377 T ES88306377 T ES 88306377T ES 88306377 T ES88306377 T ES 88306377T ES 2045126 T3 ES2045126 T3 ES 2045126T3
Authority
ES
Spain
Prior art keywords
alkyl
alcoxi
substitutes
halo
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88306377T
Other languages
English (en)
Inventor
Kelvin Dr Cooper
Michael Jonathan Dr Fray
Peter Edward Dr Cross
Kenneth Dr Richardson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Pfizer Inc
Original Assignee
Pfizer Ltd
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd, Pfizer Inc filed Critical Pfizer Ltd
Application granted granted Critical
Publication of ES2045126T3 publication Critical patent/ES2045126T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION PROPORCIONA COMPUESTOS DE FORMULA (I), DONDE R2 ES FENILO, OPCIONALMENTE SUSTITUIDO POR UNO O MAS SUSTITUYENTES, CADA UNO INDEPENDIENTEMENTE ELEGIDO ENTRE NITRO, HALO, ALQUILO C1-C4, ALCOXI C1-C4, FLUOROALCOXI C1-C4, ARILALCOXI C1-C4, ALQUILO C1-C4, ALQUILSULFONILO C1-C4, HIDROXILO, TRIFLUOROMETILO Y CIANO; R1 ES ALQUILO C1-C6 O ARILALQUILO C1-C4; Y ES ALQUILENO C2-C8, QUE PUEDE SER DE CADENA RECTA O RAMIFICADA, QUE TIENE 2 ATOMOS DE CARBONO POR LO MENOS EN LA CADENA QUE UNE X AL ATOMO DE OXOGENO; X ES 1-IMIDAZOLILO, OPCIONALMENTE SUSTITUIDO CON 1-3 SUSTITUYENTES, QUE PUEDEN SER GRUPOS ALQUILO C1-C4 O ATOMOS DE HALOGENO; O DONDE LAS POSICIONES 3 Y 4 PUEDEN ESTAR UNIDAS POR -(CH2)P-, DONDE P ES 3 O 4; O 1- O 2-BENZIMIDAZOLILO, OPCIONALMENTE SUSTITUIDO POR UNO O MAS SUSTITUYENTES, ELEGIDO CADA UNO ENTRE ALQUILO C1-C4, ALCOXI C1-C4, HALO CF3 Y CN; Y Z COMPLETA UN ANILLO CARBOCICLICO HETEROCICLICO DE 5 O 6 MIEMBROS, QUE TIENE UN GRUPO CARBONILO EN LA POSICION 5 DEL ANILLO DIHIDROPIRIDINICO; DONDE "ARIL" SIGNIFICA FENILO, OPCIONALMENTE SUSTITUIDO POR UNO O MAS SUSTITUYENTES, ELEGIDO CADA UNO INDEPENDIENTEMENTE ENTRE HALO, CF3, ALQUILO C1-C4, HIDROXILO, ALCOXI C1-C4, ALCOXI C1-C4 CARBONILO, SULFAMOILO Y CIANO.
ES88306377T 1987-07-17 1988-07-13 Agentes terapeuticos. Expired - Lifetime ES2045126T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878716971A GB8716971D0 (en) 1987-07-17 1987-07-17 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2045126T3 true ES2045126T3 (es) 1994-01-16

Family

ID=10620868

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88306377T Expired - Lifetime ES2045126T3 (es) 1987-07-17 1988-07-13 Agentes terapeuticos.

Country Status (11)

Country Link
US (2) US4853392A (es)
EP (1) EP0299727B1 (es)
JP (1) JPS6438070A (es)
AT (1) ATE69445T1 (es)
DE (1) DE3866175D1 (es)
DK (1) DK397988A (es)
ES (1) ES2045126T3 (es)
FI (1) FI883381A7 (es)
GB (1) GB8716971D0 (es)
GR (1) GR3003118T3 (es)
PT (1) PT88003B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166031A (en) * 1987-10-19 2000-12-26 Pfizer Inc, Substituted tetralins, chromans and related compounds in the treatment of asthma
GB8907401D0 (en) * 1989-04-01 1989-05-17 Pfizer Ltd Therapeutic agents
TW232013B (es) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
US5455253A (en) * 1992-10-20 1995-10-03 Zeneca Limited Heterocyclic derivatives
AU1860995A (en) * 1994-03-08 1995-09-25 Takeda Chemical Industries Ltd. Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
US20050009717A1 (en) * 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US6538004B2 (en) 2000-03-03 2003-03-25 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
EP2266984A1 (en) * 2009-06-26 2010-12-29 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4677210A (en) * 1985-06-19 1987-06-30 Rorer Pharmaceutical Corporation 1-arylalkoxy- and 1-arylalkylthioaryl-2-pyrazolines as anti-inflammatory or anti-allergic agents
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
GB8620880D0 (en) * 1986-08-29 1986-10-08 Pfizer Ltd Therapeutic agents
NO874194L (no) * 1986-11-07 1988-05-09 Pfizer Ltd Fremgangsmaate ved fremstilling av dihydro-pyridinderivater

Also Published As

Publication number Publication date
US4853392A (en) 1989-08-01
DE3866175D1 (de) 1991-12-19
GB8716971D0 (en) 1987-08-26
JPS6438070A (en) 1989-02-08
EP0299727B1 (en) 1991-11-13
EP0299727A1 (en) 1989-01-18
DK397988D0 (da) 1988-07-15
PT88003B (pt) 1995-03-01
ATE69445T1 (de) 1991-11-15
GR3003118T3 (en) 1993-02-17
FI883381A7 (fi) 1989-01-18
PT88003A (pt) 1989-06-30
US4992447A (en) 1991-02-12
DK397988A (da) 1989-01-18
FI883381A0 (fi) 1988-07-15

Similar Documents

Publication Publication Date Title
ES2185665T3 (es) Derivados de benzofurano como antagonistas de taquicininas.
ES2046202T3 (es) Un procedimiento para preparar un analogo de distamicina a.
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
ES2062460T3 (es) Nuevos derivados de la isoindolona, su preparacion y las composiciones farmaceuticas que les contienen.
ES2094653T3 (es) Derivados de indol como antagonistas de tipo 5-ht1 para uso en la migraña.
ES2159714T3 (es) Hidroximetil-imidazodiazepinas y sus esteres.
PE14696A1 (es) Derivado de fenetanolamina
ATE63744T1 (de) 3-amino-dihydro-(1>-benzopyrane und benzothiopyrane.
MX9204858A (es) Mejoras en derivados de 2-(piperazinoalquil)indol condensados en posiciones 1,7, asi como un procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
ES2108595B1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
ES2123122T3 (es) Derivados de tetrahidrocarbazol como agonistas similares a 5-ht1.
ES2081858T3 (es) Compuestos de beta-fenoxinitrilo.
ES2187652T3 (es) N-(arimetil-sustutuidas-4-(bis(fenil o piridil sustituidas)metil) piperidinas insecticidas.
DE3470538D1 (de) Ureum derivatives
DE3470740D1 (en) Herbicidal sulfonyl ureas
MX9102667A (es) Mejoras en compuestos farmacologicamente activos y procedimiento para la preparacion de dichos compuestos.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.
ES2038159T3 (es) Procedimiento para preparar derivados sustituidos de 2-aminoacetamida.
ES2035919T3 (es) Composiciones fungicidas.
ATE41149T1 (de) Substituierte furazane.
DK11189A (da) Synergistisk herbicid-komposition med indhold af bifenox og sulfonamid
ES8401966A1 (es) Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas.
ES2161892T3 (es) Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 299727

Country of ref document: ES